Drug intelligence / Profile preview

lactobacillus plantarum 299v + galacto-oligosaccharides

Development stage
Unknown
Lead developer
Probi
Modality
Small Molecules, Live Biotherapeutic Products → Microbiome Therapeutics
Administration
Oral
01

Overview

lactobacillus plantarum 299v + galacto-oligosaccharides is a synbiotic combination consisting of the probiotic strain Lactobacillus plantarum 299v (LP299V) and the prebiotic galacto-oligosaccharides (GOS). LP299V is a well-documented Gram-positive bacterium that colonizes the human intestinal mucosa by binding to mannose-specific receptors, thereby enhancing the intestinal barrier and competing with pathogenic bacteria. Galacto-oligosaccharides are non-digestible carbohydrates that serve as a substrate for beneficial gut bacteria, selectively promoting the growth of Bifidobacteria and Lactobacilli. This combination is primarily utilized to manage symptoms of irritable bowel syndrome (IBS), such as abdominal pain, bloating, and irregular bowel movements, by modulating the gut microbiota and reducing intestinal inflammation. It is typically marketed as a dietary supplement or nutraceutical.

Other names
LP299V + GOSLactobacillus plantarum 299v and galacto-oligosaccharides

Beyond the preview

Go deeper on lactobacillus plantarum 299v + galacto-oligosaccharides.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Full profile access

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Full profile access

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Full profile access

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Full profile access

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Full profile access

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on lactobacillus plantarum 299v + galacto-oligosaccharides.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call